[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @RAH00084 RAH RAH posts on X about h2, events, tox, $112m the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1450478271179759623/interactions)  - X Week XXXXXX +18% - X Month XXXXXX -XXXX% - X Months XXXXXXX -XX% - X Year XXXXXXX -XX% ### Mentions: X [#](/creator/twitter::1450478271179759623/posts_active)  - X Months XX -XX% - X Year XXX -XX% ### Followers: XXXXX [#](/creator/twitter::1450478271179759623/followers)  - X Week XXXXX +0.65% - X Month XXXXX +1.70% - X Months XXXXX +4.40% - X Year XXXXX +4.40% ### CreatorRank: XXXXXXX [#](/creator/twitter::1450478271179759623/influencer_rank)  ### Social Influence [#](/creator/twitter::1450478271179759623/influence) --- **Social category influence** [finance](/list/finance) [stocks](/list/stocks) **Social topic influence** [h2](/topic/h2), [events](/topic/events), [tox](/topic/tox), [$112m](/topic/$112m), [$70m](/topic/$70m), [$18bn](/topic/$18bn), [vice president](/topic/vice-president), [artificial](/topic/artificial), [transformative](/topic/transformative), [vice](/topic/vice) **Top assets mentioned** [Artificial Intelligence (AI4)](/topic/$ai4) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts [#](/creator/twitter::1450478271179759623/posts) --- Top posts by engagements in the last XX hours "#AVCT 🗓 X years in-clinic on Aug XX ♥ zero serious cardio tox events 🥼90+ patients dosed 🩻 Phase 1b dosing TNBC/SGC/STS ✍ Deal window for AVA6000 H2 2025 🧬 AVA6103 in-human early 2026 🗓 AVA6000 registrational trial early 2026 🩺 world class SAB"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1946096528029835673) 2025-07-18 06:35:43 UTC 2468 followers, 4136 engagements "#AVCT This is what $1.8Bn looked like last year: Profound Bio was a ADC startup led by Seagen veterans founded in 2018. It had two rounds of funding. Series A - $70m; Series B - $112M (February 2024) ProfoundBio was taken over two months after their series B funding in April 2024. Acquired by Genmab. Deal value: $1.8Bn. Lead asset: TOP1 ADC Rina S a drug designed to target tumors that express a protein called folate receptor alpha. Phase: completed Phase X of a Phase 1/2 study. Indications: Ovarian (and other indications which were high in FR-expression). Public results at time of take over:"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1947002919028449465) 2025-07-20 18:37:24 UTC 2467 followers, 7797 engagements "$484m Erasca is using Tempus to better define their clinical approach. So is Astra Zeneca GSK and others. Erasca has a pipeline of X drugs. It has traded over $1Bn market cap this year. None of its drugs are in clinic. #AVCT is valued at $200m on X years of clinical data"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1948640187933667613) 2025-07-25 07:03:19 UTC 2467 followers, 2859 engagements "Only 6p required to get back to 50p placing (a placing which only occurred as former management couldnt run a piss up in a brewery). Since the 50p placing #AVCT has a year more data commenced P1b (seeing efficacy in both SGC and TNBC) and is beating the benchmark in SGC"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1948665857653309787) 2025-07-25 08:45:19 UTC 2468 followers, 2669 engagements "When #AVCT shortly taps 50p ask yourself what premium a year more data should command on a raise which took place at a XX% to the closing price over a year ago. Then look to see what the clinicians are now saying about FAP-Dox"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1948749171369890083) 2025-07-25 14:16:23 UTC 2468 followers, 3143 engagements "The first 1m of volume took X seven minutes this morning at #AVCT. GSA scrambling to close their short surely"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1949731220427845866) 2025-07-28 07:18:41 UTC 2468 followers, 3042 engagements "Pharmacyclics was acquired by AbbVie for $21Bn in 2015. Sales of Imbruvica are now taking a hit from BeiGenes drug Brukinsa. It happens. Its pharma. Pharmacyclics did x200 from its low for these projected sales. #AVCT can too. Its not the stretch it appears if you understand preCISION. Heres just one (actually quite conservative) route: ➡ AVA6000 replaces the benchmark (which is currently a cocktail of drugs) in salivary gland cancer (SGC) and runs 400m sales pa in 3/4 years (assume pharma pay x4 for those sales in said indication) 1.6Bn. Beating the benchmark now very likely according to the"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1926524708331180087) 2025-05-25 06:24:18 UTC 2468 followers, 22.9K engagements "#AVCT SGC (30w+ PFS vs 15w benchmark) Peak sales c.250m pa x5 multiple 1.25Bn TNBC (initial efficacy demonstrated therefore the mechanism of action is working just as it has in SGC/STS) Peak sales c.1.5Bn pa x5 multiple 7.5Bn Total 8.75Bn from two indications in FAP-Dox Assume 500m shares total issuance (c.400m today) XXXXX per share Assumed chance of success today at 34p = XXX% Thick. As. Mince"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1946101770624643146) 2025-07-18 06:56:33 UTC 2468 followers, 2699 engagements "For the first time in its history #AVCT has strategic leadership (@hughesy0707) combined with impeccable clinical strategy (@coughlin582). Richard Hughes has not only hit the ground running he has wrong footed Heights & GSA in the space of a week. What does he do next 💥"  [@RAH00084](/creator/x/RAH00084) on [X](/post/tweet/1949007048886100376) 2025-07-26 07:21:05 UTC 2468 followers, 5416 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RAH00084 RAH
RAH posts on X about h2, events, tox, $112m the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX +18%
- X Month XXXXXX -XXXX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX -XX%
Mentions: X #
- X Months XX -XX%
- X Year XXX -XX%
Followers: XXXXX #
- X Week XXXXX +0.65%
- X Month XXXXX +1.70%
- X Months XXXXX +4.40%
- X Year XXXXX +4.40%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence finance stocks
Social topic influence h2, events, tox, $112m, $70m, $18bn, vice president, artificial, transformative, vice
Top assets mentioned Artificial Intelligence (AI4) AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"#AVCT 🗓 X years in-clinic on Aug XX ♥ zero serious cardio tox events 🥼90+ patients dosed 🩻 Phase 1b dosing TNBC/SGC/STS ✍ Deal window for AVA6000 H2 2025 🧬 AVA6103 in-human early 2026 🗓 AVA6000 registrational trial early 2026 🩺 world class SAB"
@RAH00084 on X 2025-07-18 06:35:43 UTC 2468 followers, 4136 engagements
"#AVCT This is what $1.8Bn looked like last year: Profound Bio was a ADC startup led by Seagen veterans founded in 2018. It had two rounds of funding. Series A - $70m; Series B - $112M (February 2024) ProfoundBio was taken over two months after their series B funding in April 2024. Acquired by Genmab. Deal value: $1.8Bn. Lead asset: TOP1 ADC Rina S a drug designed to target tumors that express a protein called folate receptor alpha. Phase: completed Phase X of a Phase 1/2 study. Indications: Ovarian (and other indications which were high in FR-expression). Public results at time of take over:" @RAH00084 on X 2025-07-20 18:37:24 UTC 2467 followers, 7797 engagements
"$484m Erasca is using Tempus to better define their clinical approach. So is Astra Zeneca GSK and others. Erasca has a pipeline of X drugs. It has traded over $1Bn market cap this year. None of its drugs are in clinic. #AVCT is valued at $200m on X years of clinical data" @RAH00084 on X 2025-07-25 07:03:19 UTC 2467 followers, 2859 engagements
"Only 6p required to get back to 50p placing (a placing which only occurred as former management couldnt run a piss up in a brewery). Since the 50p placing #AVCT has a year more data commenced P1b (seeing efficacy in both SGC and TNBC) and is beating the benchmark in SGC" @RAH00084 on X 2025-07-25 08:45:19 UTC 2468 followers, 2669 engagements
"When #AVCT shortly taps 50p ask yourself what premium a year more data should command on a raise which took place at a XX% to the closing price over a year ago. Then look to see what the clinicians are now saying about FAP-Dox" @RAH00084 on X 2025-07-25 14:16:23 UTC 2468 followers, 3143 engagements
"The first 1m of volume took X seven minutes this morning at #AVCT. GSA scrambling to close their short surely" @RAH00084 on X 2025-07-28 07:18:41 UTC 2468 followers, 3042 engagements
"Pharmacyclics was acquired by AbbVie for $21Bn in 2015. Sales of Imbruvica are now taking a hit from BeiGenes drug Brukinsa. It happens. Its pharma. Pharmacyclics did x200 from its low for these projected sales. #AVCT can too. Its not the stretch it appears if you understand preCISION. Heres just one (actually quite conservative) route: ➡ AVA6000 replaces the benchmark (which is currently a cocktail of drugs) in salivary gland cancer (SGC) and runs 400m sales pa in 3/4 years (assume pharma pay x4 for those sales in said indication) 1.6Bn. Beating the benchmark now very likely according to the" @RAH00084 on X 2025-05-25 06:24:18 UTC 2468 followers, 22.9K engagements
"#AVCT SGC (30w+ PFS vs 15w benchmark) Peak sales c.250m pa x5 multiple 1.25Bn TNBC (initial efficacy demonstrated therefore the mechanism of action is working just as it has in SGC/STS) Peak sales c.1.5Bn pa x5 multiple 7.5Bn Total 8.75Bn from two indications in FAP-Dox Assume 500m shares total issuance (c.400m today) XXXXX per share Assumed chance of success today at 34p = XXX% Thick. As. Mince" @RAH00084 on X 2025-07-18 06:56:33 UTC 2468 followers, 2699 engagements
"For the first time in its history #AVCT has strategic leadership (@hughesy0707) combined with impeccable clinical strategy (@coughlin582). Richard Hughes has not only hit the ground running he has wrong footed Heights & GSA in the space of a week. What does he do next 💥" @RAH00084 on X 2025-07-26 07:21:05 UTC 2468 followers, 5416 engagements